Possible variations in the effect according to subpopulation cannot be summarised across studies due to insufficient information; such interaction effects may be significant, as shown by the sensitivity analysis done by Lyu et al showing a 46% hazard reduction in prediabetics, which is much higher compared to the 8% reduction found in non-prediabetics 14 .
← all excerpts
Denosumab's Role in Reducing Type 2 Diabetes Risk and Improving Glycaemic Control in Osteoporotic Patients - A Meta-analysis.
1
—
—